eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2014
vol. 18
 
Share:
Share:
abstract:
Review paper

The diagnostics of colorectal cancer

Magdalena Świderska
,
Barbara Choromańska
,
Ewelina Dąbrowska
,
Emilia Konarzewska-Duchnowska
,
Katarzyna Choromańska
,
Grzegorz Szczurko
,
Piotr Myśliwiec
,
Jacek Dadan
,
Jerzy Robert Ładny
,
Krzysztof Zwierz

Contemp Oncol (Pozn) 2014; 18 (1): 1–6
Online publish date: 2013/12/20
View full text Get citation
 
PlumX metrics:
Colorectal cancer (CRC) is one of the most frequent human malignant neoplasms. CRC has an estimated incidence of more than 1,000,000 new cases annually worldwide. Approximately one out of three people who develop CRC dies from the disease. Furthermore, CRC often affects inhabitants of industrialized countries in comparison to less developed countries. Several markers of colon cancer, including CEA, CA-19-9, TPS, TAG-72 and lysosomal hydrolases, have been identified and are now being adopted in routine clinical practice. Increased values of these markers are often the first signal of recurrence or metastases, which is useful in prediction and prognosis of clinical outcome of patients with CRC. Determination of the activity of lysosomal exoglycosidases in body fluids may bring some hope of improving diagnosis of colorectal cancer. However, it has to be remembered that currently the most effective diagnostic method of CRC is endoscopy.
keywords:

colorectal cancer, tumor markers, endoscopy, lysosomal exoglycosidases

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.